［1］Wang S F, Xu L, Feng J N, et al. Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis［J］. Front Oncol, 2019, 9: 1513.
［2］Vincent Rajkumar S. Multiple myeloma: 2014 update on diagnosis, risk-stratification, and management［J］. Am J Hematol, 2014, 89(10): 999－1009.
［3］Fernández de Larrea C, Tovar N, Cibeira M T, et al. Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents［J］. Haematologica, 2011, 96(1): 171－173.
［4］Wadhera R K, Kyle R A, Larson D R, et al. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma［J］. Blood, 2011, 118(11): 2985－2987.
［5］Zou D H, An G, Zhu G Q, et al. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias［J］. Biol Blood Marrow Transplant, 2014, 20(3): 319－325.
［6］Oliver-Caldes A, Soler-Perromat J C, Lozano E, et al. Long-term responders after autologous stem cell transplantation in multiple myeloma［J］. Front Oncol, 2022, 12: 936993.
［7］Paul C, Chakraborty S, Chakraborty S. Emergence of oligoclonal bands in association with the use of chemotherapy and hematopoietic stem cell transplantation［J］. Indian J Clin Biochem, 2022, 37(3): 328－334.
［8］Ye R, Kundrapu S, Gerson S L, et al. Immune signatures associated with clonal isotype Switch after autologous stem cell transplantation for multiple myeloma［J］. Clin Lymphoma Myeloma Leuk, 2019, 19(5): e213-e220.
［9］Schmitz M F, Otten H G, Franssen L E, et al. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma［J］. Haematologica, 2014, 99(12): 1846－1853.
［10］刘佳慧, 樊慧守, 严文强, 等. 多发性骨髓瘤患者出现寡克隆条带的临床意义［J］. 中国实验血液学杂志, 2022, 30(5): 1453－1463.
［11］史青林, 徐影, 王静, 等. 多发性骨髓瘤患者自体造血干细胞移植后寡克隆条带形成对疗效及预后的影响［J］. 中华医学杂志, 2024, 104(7): 514－520.
［12］曹莉, 王莹, 曹江, 等. 寡克隆条带和(或)Ig同型转换对多发性骨髓瘤的疗效和预后评价的意义［J］. 临床血液学杂志, 2022, 35(9): 639－644.
［13］Silva L S V D, Crusoe E D Q, Souza L R G D, et al. For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission［J］. Rev Bras Hematol Hemoter, 2017, 39(4): 331－336.
［14］Rahlff J, Trusch M, Haag F, et al. Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation［J］. Cancer Immunol Immunother, 2012, 61(10): 1639－1651.
［15］Geng C Y, Yang G Z, Wang H J, et al. Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients［J］. Leuk Lymphoma, 2021, 62(4): 883－890.
［16］Vyas S G, Singh G. Prospective identification of oligoclonal/abnormal band of the same immunoglobulin type as the malignant clone by differential location of M-spike and oligoclonal band［J］. J Clin Med Res, 2017, 9(10): 826－830.
［17］Singh G. Serum and urine protein electrophoresis and Serum-free light chain assays in the diagnosis and monitoring of monoclonal gammopathies［J］. J Appl Lab Med, 2020, 5(6): 1358－1371.
|
